Importer of Controlled Substances Application: Cambrex Charles City, 30982 [2021-12215]

Download as PDF 30982 Federal Register / Vol. 86, No. 110 / Thursday, June 10, 2021 / Notices Management Ltd, London, UNITED KINGDOM; Ameren Services, St. Louis, MO; Anterix, Woodland Park, NJ; ATT Business, Dallas, TX; BEC Technologies, Richardson, TX; Blinq Network, Markham, CANADA; Bridgewater Group Consulting, Irvine, CA; Burns and McDonnell, Kansas City, MO; Cisco, San Jose, CA; Council Rock, Rochester, NY; CrescoNet, San Francisco, CA; Encore Networks, Chantilly, VA; Ericsson, Plano, TX; Evergy, Kansas City, MO; GE Industrial Communications, Rochester, NY; Hitachi-ABB, Raleigh, NC; JEA, Jacksonville, FL; K and A Engineering, White Plains, NY; L3 Harris, Rochester, NY; Mimomax Wireless, Christchurch, NEW ZEALAND; Motorola Solutions, Chicago, IL; Multi Tech Systems, Mounds View, MN; Nokia, Coppell, TX; NovaTech, Lenexa, KS; National Rural Telecommunications Cooperative, Herndon, VA; NY Power Authority (NYPA), White Plains, NY; Palmetto Technology Associates, Kiawah Island, SC; Puloli, Inc., San Francisco, CA; Southern California Edison, Rosemead, CA; SouthernLinc, Atlanta, GA; Telit Wireless Solutions, Durham, NC; World Wide Technology, Maryland Heights, MO; and Xcel Energy, Minneapolis, MN. UBBA was formed as a Delaware nonstock member corporation. The general area of UBBA’s planned activity is to empower utilities and ecosystem partners to champion the development of utility broad-band networks as a key enabler of the utility of the future, and to undertake such other activities as may from time to time be appropriate to further the purposes and achieve the goals set forth above. Membership in UBBA remains open and UBBA intends to file additional written notifications disclosing all changes in membership. Suzanne Morris, Chief, Premerger and Division Statistics, Antitrust Division. [FR Doc. 2021–12180 Filed 6–9–21; 8:45 am] BILLING CODE 4410–11–P Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before July 12, 2021. Such persons may also file a written request for a hearing on the application on or before July 12, 2021. DATES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: In accordance with 21 CFR 1301.34(a), this is notice that on May 6, 2021, Cambrex Charles City, 1205 11th Street, Charles City, Iowa 50616–3466, applied to be registered as an importer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: Drug code Controlled substance 4-Anilino-N-Phenethyl4-Piperidine (ANPP). Phenylacetone .............. Coca leaves .................. Opium, raw ................... Poppy Straw Concentrate. Drug Enforcement Administration [Docket No. DEA–847] Importer of Controlled Substances Application: Cambrex Charles City Drug Enforcement Administration, Justice. ACTION: Notice of application. William T. McDermott, Assistant Administrator. Cambrex Charles City has applied to be registered as an importer BILLING CODE 4410–09–P AGENCY: SUMMARY: VerDate Sep<11>2014 17:15 Jun 09, 2021 Jkt 253001 Schedule 8333 II 8501 9040 9600 9670 II II II II The company plans to import the listed controlled substances for internal use and to bulk manufacture other controlled substances in Active Pharmaceutical Ingredient (API) form for distribution to its customers. No other activity for these drug codes is authorized for this registration. DEPARTMENT OF JUSTICE khammond on DSKJM1Z7X2PROD with NOTICES of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. [FR Doc. 2021–12215 Filed 6–9–21; 8:45 am] PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–844] Importer of Controlled Substances Application: Fisher Clinical Services, Inc. Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before July 12, 2021. Such persons may also file a written request for a hearing on the application on or before July 12, 2021. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on May 17, 2021, Fisher Clinical Services, Inc. 7554 Schantz Road, Allentown, Pennsylvania 18106– 9032 applied to be registered as an importer of the following basic class(es) of controlled substance(s): SUMMARY: Controlled substance Marihuana Extract ........ Drug code 7350 Schedule I The company plans to import the listed controlled substances for clinical trails only. No other activity for these drug codes is authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the E:\FR\FM\10JNN1.SGM 10JNN1

Agencies

[Federal Register Volume 86, Number 110 (Thursday, June 10, 2021)]
[Notices]
[Page 30982]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-12215]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-847]


Importer of Controlled Substances Application: Cambrex Charles 
City

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Cambrex Charles City has applied to be registered as an 
importer of basic class(es) of controlled substance(s). Refer to 
Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before July 12, 2021. 
Such persons may also file a written request for a hearing on the 
application on or before July 12, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
request for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on May 6, 2021, Cambrex Charles City, 1205 11th Street, 
Charles City, Iowa 50616-3466, applied to be registered as an importer 
of the following basic class(es) of controlled substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
4-Anilino-N-Phenethyl-4-Piperidine          8333  II
 (ANPP).
Phenylacetone..........................     8501  II
Coca leaves............................     9040  II
Opium, raw.............................     9600  II
Poppy Straw Concentrate................     9670  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
internal use and to bulk manufacture other controlled substances in 
Active Pharmaceutical Ingredient (API) form for distribution to its 
customers. No other activity for these drug codes is authorized for 
this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-12215 Filed 6-9-21; 8:45 am]
BILLING CODE 4410-09-P